Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVARREST vs SURGICEL for Bleeding Control in Pediatric Surgery
NCT02227992Phase 3Completed
- Sponsor
- Ethicon
- Start
- Jul 2014
- Primary completion
- Oct 2021
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery
- Countries
- 2
01
Overview
A Phase 3 trial of Fibrin Pad in postoperative hemorrhage, sponsored by Ethicon. Started Jul 2014; status: completed.
02
Drugs
Fibrin Pad
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT02227992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02227992.